SYNH - Syneos Health joins hand with Equicare to accelerate clinical trial reserach
- Syneos Health ( NASDAQ: SYNH ) announced a strategic partnership with Equicare to use proXimity, a cloud-based software platform that accelerates the transfer of clinical trial subject data from multiple electronic health records (or EHR) to the sponsor’s electronic data capture systems (or EDC).
- Through the partnership, Syneos Health will use the proXimity platform to automate sponsor data transfers from EHRs to EDCs for clinical trials, helping to accelerate the performance of new therapies for patients.
- “We are using proXimity today for many of our studies and we are realizing the benefits as we are delivering the data to our sponsors more quickly with less errors. In 2023, NEXT Oncology will utilize proXimity on all studies that utilize Medidata Rave as the EDC. We know this is the future to bring new therapies to cancer patients faster, and we are glad to have Syneos Health’s support with this strategy.” said Dr. Anthony Tolcher, MD, Medical Oncologist and co-founder of NEXT Oncology.
For further details see:
Syneos Health joins hand with Equicare to accelerate clinical trial reserach